KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$6.37
+0.215 (+3.49%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Mar 27, 2024 Sell 348 Catinazzo Thomas Common Stock
Mar 27, 2024 Sell 765 Bergstrom Donald A Common Stock
Mar 27, 2024 Sell 298 Rahmer Peter Common Stock
Mar 27, 2024 Sell 348 Adams Brian Common Stock
Jan 29, 2024 Sell 1 651 Rahmer Peter Common Stock
Jan 29, 2024 Sell 2 005 Catinazzo Thomas Common Stock
Jan 29, 2024 Sell 3 178 Bergstrom Donald A Common Stock
Jan 29, 2024 Sell 1 929 Adams Brian Common Stock
Jan 16, 2024 Buy 200 000 Rahmer Peter Common Stock
Jan 16, 2024 Buy 762 360 Patel Sanjiv Common Stock
Jan 16, 2024 Buy 200 000 Catinazzo Thomas Common Stock
Jan 16, 2024 Buy 300 000 Bergstrom Donald A Common Stock
Jan 16, 2024 Buy 200 000 Adams Brian Common Stock
Dec 27, 2023 Sell 244 Rahmer Peter Common Stock
Dec 27, 2023 Sell 294 Catinazzo Thomas Common Stock
Dec 27, 2023 Sell 977 Bergstrom Donald A Common Stock
Dec 27, 2023 Sell 294 Adams Brian Common Stock
Oct 30, 2023 Sell 1 354 Rahmer Peter Common Stock
Oct 30, 2023 Sell 1 697 Catinazzo Thomas Common Stock
Oct 30, 2023 Sell 3 451 Bergstrom Donald A Common Stock
Oct 30, 2023 Sell 1 632 Adams Brian Common Stock
Sep 27, 2023 Sell 648 Bergstrom Donald A Common Stock
Sep 27, 2023 Sell 244 Rahmer Peter Common Stock
Sep 27, 2023 Sell 294 Catinazzo Thomas Common Stock
Sep 27, 2023 Sell 294 Adams Brian Common Stock
Jul 28, 2023 Sell 1 352 Rahmer Peter Common Stock
Jul 28, 2023 Sell 1 693 Catinazzo Thomas Common Stock
Jul 28, 2023 Sell 2 683 Bergstrom Donald A Common Stock
Jul 28, 2023 Sell 1 628 Adams Brian Common Stock
Jun 30, 2023 Buy 1 662 Patel Sanjiv Common Stock
Jun 30, 2023 Buy 1 228 Bergstrom Donald A Common Stock
Jun 30, 2023 Buy 1 662 Rahmer Peter Common Stock
Jun 27, 2023 Sell 244 Rahmer Peter Common Stock
Jun 27, 2023 Sell 294 Catinazzo Thomas Common Stock
Jun 27, 2023 Sell 647 Bergstrom Donald A Common Stock
Jun 27, 2023 Sell 294 Adams Brian Common Stock
May 31, 2023 Buy 66 055 Hill Linda A Stock Option (Right to Buy)
May 31, 2023 Buy 66 055 Ingram Douglas S Stock Option (Right to Buy)
May 31, 2023 Buy 66 055 Kathiresan Sekar Stock Option (Right to Buy)
May 31, 2023 Buy 66 055 Murcko Mark Stock Option (Right to Buy)
May 31, 2023 Buy 66 055 Rubin Jami Stock Option (Right to Buy)
May 31, 2023 Buy 66 055 Shawver Laura Stock Option (Right to Buy)
May 31, 2023 Buy 66 055 Borisy Alexis Stock Option (Right to Buy)
May 30, 2023 Buy 161 818 Rahmer Peter Common Stock
May 24, 2023 Sell 12 099 Shawver Laura Common Stock
Apr 28, 2023 Sell 1 657 Rahmer Peter Common Stock
Apr 28, 2023 Sell 2 012 Catinazzo Thomas Common Stock
Apr 28, 2023 Sell 2 850 Bergstrom Donald A Common Stock
Apr 28, 2023 Sell 1 936 Adams Brian Common Stock
Apr 28, 2023 Sell 739 Rahmer Peter Common Stock
Apr 28, 2023 Sell 863 Catinazzo Thomas Common Stock
Apr 28, 2023 Sell 1 383 Bergstrom Donald A Common Stock
Apr 28, 2023 Sell 863 Adams Brian Common Stock
Mar 27, 2023 Sell 297 Rahmer Peter Common Stock
Mar 27, 2023 Sell 347 Catinazzo Thomas Common Stock
Mar 27, 2023 Sell 763 Bergstrom Donald A Common Stock
Mar 27, 2023 Sell 347 Adams Brian Common Stock
Feb 09, 2023 Sell 14 000 Patel Sanjiv Stock Option (Right to Buy)
Feb 09, 2023 Buy 14 000 Patel Sanjiv Common Stock
Feb 09, 2023 Sell 14 000 Patel Sanjiv Common Stock
Feb 08, 2023 Sell 14 000 Patel Sanjiv Stock Option (Right to Buy)
Feb 08, 2023 Sell 14 000 Patel Sanjiv Common Stock
Feb 07, 2023 Sell 14 000 Patel Sanjiv Stock Option (Right to Buy)
Feb 07, 2023 Sell 14 000 Patel Sanjiv Common Stock
Jan 30, 2023 Sell 740 Rahmer Peter Common Stock
Jan 30, 2023 Sell 864 Catinazzo Thomas Common Stock
Jan 30, 2023 Sell 1 429 Bergstrom Donald A Common Stock
Jan 30, 2023 Sell 864 Adams Brian Common Stock
Jan 19, 2023 Sell 28 000 Patel Sanjiv Stock Option (Right to Buy)
Jan 19, 2023 Buy 28 000 Patel Sanjiv Common Stock
Jan 19, 2023 Sell 28 000 Patel Sanjiv Common Stock
Jan 18, 2023 Sell 28 000 Patel Sanjiv Stock Option (Right to Buy)
Jan 17, 2023 Buy 97 630 Rahmer Peter Common Stock
Jan 17, 2023 Buy 97 630 Rahmer Peter Stock Option (Right to Buy)
Jan 17, 2023 Buy 701 680 Patel Sanjiv Stock Option (Right to Buy)
Jan 17, 2023 Sell 28 000 Patel Sanjiv Stock Option (Right to Buy)
Jan 17, 2023 Buy 101 115 Catinazzo Thomas Common Stock
Jan 17, 2023 Buy 104 600 Catinazzo Thomas Stock Option (Right to Buy)
Jan 17, 2023 Buy 97 630 Catinazzo Thomas Stock Option (Right to Buy)
Jan 17, 2023 Buy 85 425 Adams Brian Common Stock
Jan 17, 2023 Buy 97 630 Adams Brian Stock Option (Right to Buy)
Jan 17, 2023 Buy 73 220 Adams Brian Stock Option (Right to Buy)
Jan 17, 2023 Buy 160 390 Bergstrom Donald A Common Stock
Jan 17, 2023 Buy 160 390 Bergstrom Donald A Stock Option (Right to Buy)
Jan 12, 2023 Sell 9 994 Adams Brian Common Stock
Dec 31, 2022 Buy 78 540 Rahmer Peter Stock Option (Right to Buy)
Dec 31, 2022 Buy 0 Rahmer Peter Common Stock
Dec 27, 2022 Sell 445 Catinazzo Thomas Common Stock
Dec 27, 2022 Sell 980 Bergstrom Donald A Common Stock
Dec 27, 2022 Sell 295 Adams Brian Common Stock
Nov 10, 2022 Sell 9 825 Patel Sanjiv Stock Option (Right to Buy)
Nov 10, 2022 Buy 18 175 Patel Sanjiv Common Stock
Nov 10, 2022 Buy 9 825 Patel Sanjiv Common Stock
Nov 10, 2022 Sell 9 825 Patel Sanjiv Common Stock
Nov 10, 2022 Sell 18 175 Patel Sanjiv Stock Option (Right to Buy)
Nov 08, 2022 Buy 14 000 Patel Sanjiv Common Stock
Nov 08, 2022 Sell 14 000 Patel Sanjiv Stock Option (Right to Buy)
Oct 28, 2022 Buy 0 Patel Sanjiv Common Stock
Oct 28, 2022 Sell 0 Patel Sanjiv Common Stock
Oct 28, 2022 Sell 448 Porter Andy Common Stock
JSON CSV
INSIDER POWER
85.919
Last 100 transactions
Buy: 4 230 995 | Sell: 320 820 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 85.919.

In total, the insiders bought 4 230 995 and sold 320 820 RLAY shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Relay Therapeutics Inc.

Relay Therapeutics. Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for pa... RLAY Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT